CEACAM5 and neoplasm: Further studies will evaluate if core-1 and/or extended core-1 O-glycans recognized by NEO-201 are attached to other specific tumor-associated proteins (beyond CEACAM5 and CEACAM6) expressed by the different types of tumors targeted by NEO-201.